Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034931543> ?p ?o ?g. }
- W2034931543 endingPage "4904" @default.
- W2034931543 startingPage "4897" @default.
- W2034931543 abstract "Many peptide and protein drugs have a short circulatory half-life in vivo. The covalent attachment of polyethylene glycol (PEG) chains (PEGylation) can overcome this deficiency, but pegylated peptides and proteins are often inactive. In this study, we present a novel PEG−IFNα2 conjugate, PEG40-FMS−IFNα2, capable of regenerating native interferon α2 (IFNα2) at a slow rate under physiological conditions. A 2-sulfo-9-fluorenylmethoxycarbonyl (FMS) containing bifunctional reagent, MAL-FMS-NHS, has been synthesized, enabling the linkage of a 40 kDa PEG-SH to IFNα2 through a slowly hydrolyzable bond. By use of a BIAcore binding assay, the in vitro rate of regeneration of native interferon was estimated to have a half-life of 65 h. Following subcutaneous administration to rats and monitoring circulating antiviral activity, active IFNα2 levels peaked at 50 h, with substantial levels still being detected 200 h after administration. This value contrasts with a half-life of about 1 h measured for unmodified interferon. The concentration of active IFNα2 scaled linearly with the quantity injected. Comparing subcutaneous to intravenous administration of PEG40-FMS−IFNα2, we found that the long circulatory lifetime of IFNα2 was affected both by the slow rate of absorption of the PEGylated protein from the subcutaneous volume and by the slow rate of discharge from the PEG in circulation. A numerical simulation of the results was in good agreement with the results observed in vivo. The pharmacokinetic profile of this novel IFNα2 conjugate combines a prolonged maintenance in vivo with the regeneration of active-native IFNα2, ensuring ready access to peripheral tissues and thus an overall advantage over currently used formulations." @default.
- W2034931543 created "2016-06-24" @default.
- W2034931543 creator A5009956552 @default.
- W2034931543 creator A5036771303 @default.
- W2034931543 creator A5037649198 @default.
- W2034931543 creator A5039460084 @default.
- W2034931543 creator A5040074257 @default.
- W2034931543 creator A5084845625 @default.
- W2034931543 date "2004-08-25" @default.
- W2034931543 modified "2023-09-27" @default.
- W2034931543 title "Reversible PEGylation: A Novel Technology To Release Native Interferon α2 over a Prolonged Time Period" @default.
- W2034931543 cites W1523528013 @default.
- W2034931543 cites W1550814250 @default.
- W2034931543 cites W1965385720 @default.
- W2034931543 cites W1969573171 @default.
- W2034931543 cites W1976722821 @default.
- W2034931543 cites W1978045706 @default.
- W2034931543 cites W1987119060 @default.
- W2034931543 cites W2001302901 @default.
- W2034931543 cites W2009954025 @default.
- W2034931543 cites W2011370547 @default.
- W2034931543 cites W2017328990 @default.
- W2034931543 cites W2023365767 @default.
- W2034931543 cites W2025920006 @default.
- W2034931543 cites W2038445365 @default.
- W2034931543 cites W2052039265 @default.
- W2034931543 cites W2054064585 @default.
- W2034931543 cites W2069595441 @default.
- W2034931543 cites W2071442507 @default.
- W2034931543 cites W2075177037 @default.
- W2034931543 cites W2075423634 @default.
- W2034931543 cites W2092715704 @default.
- W2034931543 cites W2095930245 @default.
- W2034931543 cites W2113319384 @default.
- W2034931543 cites W2142337801 @default.
- W2034931543 cites W2149220251 @default.
- W2034931543 cites W2170779256 @default.
- W2034931543 doi "https://doi.org/10.1021/jm0497693" @default.
- W2034931543 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15369394" @default.
- W2034931543 hasPublicationYear "2004" @default.
- W2034931543 type Work @default.
- W2034931543 sameAs 2034931543 @default.
- W2034931543 citedByCount "59" @default.
- W2034931543 countsByYear W20349315432012 @default.
- W2034931543 countsByYear W20349315432013 @default.
- W2034931543 countsByYear W20349315432014 @default.
- W2034931543 countsByYear W20349315432015 @default.
- W2034931543 countsByYear W20349315432016 @default.
- W2034931543 countsByYear W20349315432019 @default.
- W2034931543 countsByYear W20349315432020 @default.
- W2034931543 countsByYear W20349315432021 @default.
- W2034931543 countsByYear W20349315432022 @default.
- W2034931543 countsByYear W20349315432023 @default.
- W2034931543 crossrefType "journal-article" @default.
- W2034931543 hasAuthorship W2034931543A5009956552 @default.
- W2034931543 hasAuthorship W2034931543A5036771303 @default.
- W2034931543 hasAuthorship W2034931543A5037649198 @default.
- W2034931543 hasAuthorship W2034931543A5039460084 @default.
- W2034931543 hasAuthorship W2034931543A5040074257 @default.
- W2034931543 hasAuthorship W2034931543A5084845625 @default.
- W2034931543 hasConcept C10138342 @default.
- W2034931543 hasConcept C112705442 @default.
- W2034931543 hasConcept C134306372 @default.
- W2034931543 hasConcept C150903083 @default.
- W2034931543 hasConcept C162324750 @default.
- W2034931543 hasConcept C185592680 @default.
- W2034931543 hasConcept C197336794 @default.
- W2034931543 hasConcept C203014093 @default.
- W2034931543 hasConcept C207001950 @default.
- W2034931543 hasConcept C2776178377 @default.
- W2034931543 hasConcept C2776964284 @default.
- W2034931543 hasConcept C2779149719 @default.
- W2034931543 hasConcept C33923547 @default.
- W2034931543 hasConcept C54400483 @default.
- W2034931543 hasConcept C55493867 @default.
- W2034931543 hasConcept C71924100 @default.
- W2034931543 hasConcept C86803240 @default.
- W2034931543 hasConcept C98274493 @default.
- W2034931543 hasConceptScore W2034931543C10138342 @default.
- W2034931543 hasConceptScore W2034931543C112705442 @default.
- W2034931543 hasConceptScore W2034931543C134306372 @default.
- W2034931543 hasConceptScore W2034931543C150903083 @default.
- W2034931543 hasConceptScore W2034931543C162324750 @default.
- W2034931543 hasConceptScore W2034931543C185592680 @default.
- W2034931543 hasConceptScore W2034931543C197336794 @default.
- W2034931543 hasConceptScore W2034931543C203014093 @default.
- W2034931543 hasConceptScore W2034931543C207001950 @default.
- W2034931543 hasConceptScore W2034931543C2776178377 @default.
- W2034931543 hasConceptScore W2034931543C2776964284 @default.
- W2034931543 hasConceptScore W2034931543C2779149719 @default.
- W2034931543 hasConceptScore W2034931543C33923547 @default.
- W2034931543 hasConceptScore W2034931543C54400483 @default.
- W2034931543 hasConceptScore W2034931543C55493867 @default.
- W2034931543 hasConceptScore W2034931543C71924100 @default.
- W2034931543 hasConceptScore W2034931543C86803240 @default.
- W2034931543 hasConceptScore W2034931543C98274493 @default.
- W2034931543 hasIssue "20" @default.
- W2034931543 hasLocation W20349315431 @default.